Men taking MDV3100 lived for a median of 18.4 months, compared with 13.6 months for men taking placebo (p < 0.0001; HR=0.631); MDV3100 also met all secondary endpoints, including radiographic progression-free survival (8.3...
ABSTRACT This phenomenological study examined the experience of being the father of a child with severe cerebral palsy (CP). Participants were selected using purposive sampling. Two interviews were conducted with 6 English-speaking, biological...
ABSTRACT One aspect of successful aging is maintaining cognitive functioning, which includes both subjective cognitive functioning and objective cognitive functioning even in lieu of subtle cognitive deficits that occur with normal, nonpathological aging....
CAMBRIDGE, Mass. -- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the European Medicines Agency (EMA) has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme([R])...
DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/54ea7b/activated_carbon_f) has announced the addition of John Wiley and Sons Ltd's new book "Activated Carbon for Water and Wastewater Treatment: Integration of Adsorption and Biological Treatment" to their offering....
WOBURN, Mass. -- ArQule, Inc. (NASDAQ: ARQL) today announced that treatment with tivantinib as single agent therapy produced a statistically significant 56 percent improvement in time-to-progression (TTP) in the intent-to-treat (ITT) population, the...
CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the U.S. District Court of...
Leading European CRO Chooses 'Flexible and Affordable' Clinical Trial Management (CTMS) Technology NEWTOWN, Pa. -- BioClinica([R]), Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, announced today a new agreement with...
NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that dosing has initiated in a Phase 1 study of its hematopoietic growth factor, CDX-301, in healthy subjects. The study is being conducted...
ALPHARETTA, Ga. -- SANUWAVE Health, Inc. (OTCBB: SNWV) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,092,401, titled "Method and Apparatus for Producing Shock Waves...
SOUTH SAN FRANCISCO, Calif. -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of...
NEW YORK & PRINCETON, N.J. -- Bristol-Myers Squibb Company (NYSE: BMY) ("Bristol-Myers Squibb") is commencing today, through its wholly owned subsidiary Inta Acquisition Corporation, a cash tender offer to purchase all outstanding shares...
BioTrends Research Group, LLC has released findings from the LaunchTrends([R]): Xalkori report, which is tracking the launch of this new targeted therapy. The study finds that Pfizer's Xalkori (crizotinib), which is indicated for...
VICTORIA, British Columbia -- FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (AMEX: FSI, FRANKFURT: FXT), isthe developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients, water treatment and crop nutrient availability chemistry, as well...
LEBANON, N.H. -- Adimab, LLC, a leader in the discovery of fully human antibodies, today announced that its partner, Merrimack Pharmaceuticals, Inc. of Cambridge, MA, has initiated the first human clinical trial of...
Expanded Capacity Addresses Needs of Life Science Customers SAN DIEGO -- CryoPort, Inc. (OTCBB:CYRX) today announced it is increasing its line of deep frozen shipping containers with the introduction of the CryoPort Express[R]...
FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel Lynch, president and CEO, will provide an update of corporate activities at the 30th Annual J.P. Morgan Healthcare Conference on...
ROCKVILLE, Md. -- Trophogen Inc., a biotechnology company developing hormone and related growth factor analogs for human infertility, animal superovulation, and human cancers together with Advanced BioScience Laboratories Inc. (ABL), a biomedical contract...
Secure Logistics Solution Provides "Highest Medical Standard" SAN DIEGO -- CryoPort, Inc. (OTCBB: CYRX) was mentioned in a 60 MINUTES story Sunday night as the "highest medical standard" for safely and securely transporting...
Groundbreaking Cleveland Clinic Study Published in "Microvascular Research" ALPHARETTA, Ga. -- SANUWAVE Health, Inc. (OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices...